Haleon increases stake in Chinese JV Tianjin TSKF Pharmaceutical to 88%

Haleon plc, a leading name in consumer healthcare, has successfully completed the acquisition of an additional 33% equity interest in its joint venture, Tianjin TSKF ... Read More